The tumor regression grades after NAC were TRG4 (0%), TRG3 (17.6%), TRG2 (33.3%), TRG1 (35.3%), TRG0 (9.8%), and not evaluable (NE) (3.9%). This evidence concerns the gene NXN and neoplasm.